Concepedia

John M. Goldberg

JM

12

Publications

769

Citations

11

H-Index

1998

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

University of Miami

Sylvester Comprehensive Cancer Center

Children's Hospital of Los Angeles

Seattle Children's Hospital

John M. Goldberg is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1998–2022

12

Publications

12

Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience

John M. Goldberg, Lewis B. Silverman, Donna E. Levy et al. · Journal of Clinical Oncology · 2003 · 346 citations

Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor–associated tumors

Andrew J. Wagner, John M. Goldberg, Steven G. DuBois et al. · Cancer · 2012 · 154 citations

Dimethylheptyl-THC-11 OIC acid: A nonpsychoactive antiinflammatory agent with a cannabinoid template structure

Robert B. Zurier, Ronald G. Rossetti, Joan H. Lane et al. · Arthritis & Rheumatism · 1998 · 98 citations

Biologic Activity of Autologous, Granulocyte–Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines

John M. Goldberg, David E. Fisher, George D. Demetri et al. · Clinical Cancer Research · 2015 · 31 citations · Full text

Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T‐acute lymphoblastic leukemia and T‐lymphoblastic lymphoma (study T2008‐002 NECTAR)

James A. Whitlock, Jemily Malvar, Luciano Dalla‐Pozza et al. · Pediatric Blood & Cancer · 2022 · 26 citations · Full text

Rows per page

1–5 of 12